Skip to main content

Table 1 Demographic and clinical characteristics of HIV-1-infected patients

From: Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration

Characteristic

 

Absolute value

 

Number of participants

 

61

 

Number of male participants, (%)

 

56

(92%)

Age (y), median [IQR]

 

43

[35-48]

Route of transmission, (%)

   
 

homosexual

46

(76%)

 

heterosexual

13

(21%)

 

blood products

2

(3%)

Nationality, (%)

   
 

Japanese

61

(100%)

Nadir CD4 cell count (/μl), median [IQR]*

 

175

[54-256]

Pre-ART VL (copies/ml), median [IQR]*

 

85500

[41500-322500]

Current CD4 cell count (/μl), median [IQR]

 

569

[442-818]

Current ART regimen, no. (%)

   
 

PI-based

32

(52%)

 

NNRTI-based

25

(41%)

 

3-NRTI

4

(7%)

Duration of VL suppression (days), median [IQR]

 

2205

[784-2737]

  1. * Data are unavailable for seven (11%) patients. IQR, interquartile range; VL, viral load; ART, antiretroviral therapy; PI, protease inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor.